Today: 14 June 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Jabil stock slides on Hanley Energy buy: what the $725 million AI data center deal means for JBL

Jabil stock slides on Hanley Energy buy: what the $725 million AI data center deal means for JBL

Jabil shares dropped 7.3% to $222.90 after the company said it completed its $725 million cash acquisition of Hanley Energy Group. The deal, closed Jan. 2, adds 850 employees and expands Jabil’s data center power capabilities. Investors focused on integration risks and cash outlay, as Jabil’s stock fell while the broader market rose. The company’s annual meeting is set for January 22.
XRP pops again as U.S. spot ETF assets near $1.4B and buy pressure hits month-high

XRP pops again as U.S. spot ETF assets near $1.4B and buy pressure hits month-high

XRP jumped 9% to $2.27 on Monday, with U.S.-listed spot XRP ETFs taking in $43 million last week and holding $1.37 billion in assets, according to FXStreet. XRP futures open interest reached $3.8 billion. CryptoQuant reported a seven-day average taker buy/sell ratio of 0.991, the highest since November. ETF inflows have continued for 43 straight trading days since mid-November, 24/7 Wall St. said.
5 January 2026
Fabrinet stock slides nearly 7% today as contract manufacturers sell off; earnings in focus

Fabrinet stock slides nearly 7% today as contract manufacturers sell off; earnings in focus

Fabrinet shares dropped 6.7% to $447.36 by early afternoon Monday, defying gains in the S&P 500 and Nasdaq. The decline came ahead of the company’s quarterly update, with investors watching for signs of demand shifts after management set a high revenue target for the December quarter. Jabil, Celestica, and Flex also fell. The ISM manufacturing PMI slipped to 47.9 in December, signaling contraction.
Viking Therapeutics stock sinks as Novo’s Wegovy pill debut resets obesity-drug pricing

Viking Therapeutics stock sinks as Novo’s Wegovy pill debut resets obesity-drug pricing

Viking Therapeutics shares fell 9.9% to $31.93 Monday after Novo Nordisk launched its Wegovy weight-loss pill in the U.S. with starter doses priced at $149 per month for cash-pay patients. Novo’s U.S.-listed shares rose 5.1%, while Eli Lilly dropped 3.9%. Viking’s next updates include Phase 3 trial milestones in Q1 and an earnings release expected Feb. 4.
Gulfport Energy stock (GPOR) slides nearly 9% on Wolfe downgrade as gas prices fall

Gulfport Energy stock (GPOR) slides nearly 9% on Wolfe downgrade as gas prices fall

Gulfport Energy shares fell 8.7% to $188.26 after Wolfe Research downgraded the stock, citing weaker natural gas prices and a lower long-term gas forecast. U.S. natural gas dropped 3.5% to $3.49 per MMBtu. Other gas producers also declined. Investors await the Jan. 8 U.S. storage report and Gulfport’s next earnings date, estimated for late February.
SiTime stock slumps 9% after topping Wall Street targets, bucking chip rally

SiTime stock slumps 9% after topping Wall Street targets, bucking chip rally

SiTime shares fell nearly 9% to $336.50 Monday afternoon, erasing earlier gains and much of their start-of-year advance. The drop came after the stock surpassed the average analyst target of $355, drawing valuation scrutiny. The move contrasted with a 1.7% gain in the PHLX Semiconductor Index as chip stocks broadly rallied. Investors are watching for SiTime’s next earnings update.
Structure Therapeutics stock slides nearly 8% as Novo’s Wegovy pill debut jolts oral obesity-drug bets

Structure Therapeutics stock slides nearly 8% as Novo’s Wegovy pill debut jolts oral obesity-drug bets

Structure Therapeutics shares fell 7.7% to $62.86 after Novo Nordisk began U.S. sales of its Wegovy pill at $149 a month for self-paying patients. Structure’s stock had reached $72.02 earlier in the session before retreating. Investors await updates on its Phase 3 plans and next earnings report, expected Feb. 26.
Astera Labs stock drops 8% after insider sale plan disclosed — what traders watch next

Astera Labs stock drops 8% after insider sale plan disclosed — what traders watch next

Astera Labs shares dropped 8.4% to $164.50 Monday after a regulatory filing showed general counsel Philip Mazzara plans to sell 30,000 shares worth about $5 million. The stock reversed from a session high near $185, trading over 5 million shares by early afternoon. Semiconductor ETFs rose, but Astera lagged. Investors are watching for further insider filings and signals from hyperscale customers.
5 January 2026
Arrowhead Pharmaceuticals stock slides despite Health Canada approval of Redemplo — what investors watch next

Arrowhead Pharmaceuticals stock slides despite Health Canada approval of Redemplo — what investors watch next

Arrowhead Pharmaceuticals shares fell 6.9% to $63.11 Monday after Health Canada approved Redemplo, its triglyceride-lowering drug for familial chylomicronemia syndrome. The stock dropped despite the clearance, tracking weakness across biotech stocks. Investors now await Arrowhead’s obesity data webinar on Jan. 6 and its J.P. Morgan conference presentation Jan. 12.
1 307 308 309 310 311 590

Stock Market Today

  • SpaceX IPO Surges 19% in Historic Nasdaq Debut, Valuing Company at $2.1 Trillion
    June 13, 2026, 7:29 PM EDT. SpaceX, Elon Musk's aerospace and AI company, soared 19% on its Nasdaq debut, closing at $161 and marking the largest initial public offering (IPO) ever with a $2.1 trillion valuation. The shares, trading under ticker SPCX, opened at $150, with over 500 million shares exchanging hands, nearing Facebook's record first-day volume. SpaceX raised $75 billion in the IPO. Musk highlighted plans to fund ambitious projects including deploying 100,000 satellites for communications and building AI data centers in space. Despite a history of $41.3 billion losses since 2002, SpaceX's Starlink satellite internet division remains profitable. Tesla shares also rose 1.8%, pushing its market cap to $1.5 trillion. Extended trading saw SpaceX add another 3.5%, boosting market cap to $2.2 trillion.

Latest articles

Kraft Heinz Shares Rally for Six Days—Is KHC a Buy Now?

Kraft Heinz Shares Rally for Six Days—Is KHC a Buy Now?

14 June 2026
Kraft Heinz closed up 0.70% at $24.39, outpacing the S&P 500, as investors weighed its 6.6% dividend yield against falling organic sales, lower adjusted earnings, and cautious analyst targets; the next earnings update is seen as the key test for whether $600 million in marketing and R&D can revive growth and support the stock’s rebound.
Go toTop